LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Capital expenditures, 2025
- $452K
- YoY, 2025
- −75.2%
- 5-year CAGR
- −36.7%
- 10-year CAGR
- +17.1%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $452K | −75.2% |
| 2024 | $1.8M | −48.3% |
| 2023 | $3.5M | −80.4% |
| 2022 | $18M | +104.6% |
| 2021 | $8.8M | +96.5% |
| 2020 | $4.5M | +74.6% |
| 2019 | $2.6M | +187.8% |
| 2018 | $887K | −58.9% |
| 2017 | $2.2M | +16.5% |
| 2016 | $1.9M | +1,889.2% |
| 2015 | $93K | +1,450.0% |
| 2014 | $6K | −98.4% |
| 2013 | $377K | −36.6% |
| 2012 | $595K | +662.8% |
| 2011 | $78K | +11.4% |
| 2010 | $70K | −86.6% |
| 2009 | $522K | — |